{"nct_id":"NCT02142192","title":"Natalizumab Subcutaneous Immunogenicity and Safety Study","status":"TERMINATED","status_verified_date":"2024-05","start_date":"2014-12-01","start_date_type":"ACTUAL","primary_completion_date":"2015-06-04","primary_completion_date_type":"ACTUAL","completion_date":"2015-06-04","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["BIIB"]}